Wednesday, June 23, 2021

Covaxin Phase 3 data in: Efficacy 77.8% against symptomatic Covid https://ift.tt/eA8V8J



from India | The Indian Express https://ift.tt/3j7wjx8
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)